EDQM and EMA to clarify how Ph. Eur applies to biosimilars at event next week
The EDQM and EMA aim to clarify how European Pharmacopoeia (Ph. Eur) monographs apply to biosimilars at an event next week.
Archives for January 31, 2017
Patented GE bioreactor bag boasts of 214m CHO cells/mL in perfusion mode
GE Healthcare says a new inflatable bioreactor bag configured in perfusion mode can achieve a cell density over four times that of the current industry standard.
Amgen's two-brand strategy? EU thumbs up for Humira biosimilar duo
The EMA has recommended approval of two versions of AbbVie’s bestselling biologic Humira (adalimumab), both made by Amgen.